MSLN and lung carcinoma: Similarly, the potential causal relationship between an EMP-like phenotype and mesothelin expression in this cancer model remains unexplored, despite evidence in lung cancer and mesothelioma indicating that mesothelin promotes epithelial-to-mesenchymal transition and tumorigenicity in human lung cancer and mesothelioma models [76].